scholarly journals A discontinuous Galerkin model for fluorescence loss in photobleaching of intracellular polyglutamine protein aggregates

2018 ◽  
Vol 11 (1) ◽  
Author(s):  
Christian V. Hansen ◽  
Hans J. Schroll ◽  
Daniel Wüstner
2018 ◽  
Author(s):  
Christian Valdemar Hansen ◽  
Hans J Schroll ◽  
Daniel Wüstner

Background: Intracellular phase separation and aggregation of proteins with extended poly-glutamine (polyQ) stretches are hallmarks of various age-associated neurodegenerative diseases. Progress in our understanding of such processes heavily relies on quantitative fluorescence imaging of suitably tagged proteins. Fluorescence loss in photobleaching (FLIP) is particularly well-suited to study the dynamics of protein aggregation in cellular models of Chorea Huntington and other polyQ diseases, as FLIP gives access to the full spatio-temporal profile of intensity changes in the cell geometry. In contrast to other methods, also dim aggregates become visible during time evolution of fluorescence loss in cellular compartments. However, methods for computational analysis of FLIP data are sparse, and transport models for estimation of transport and diffusion parameters from experimental FLIP sequences are missing. Results: In this paper, we present a computational method for analysis of FLIP imaging experiments of intracellular polyglutamine protein aggregates also called inclusion bodies (IBs). By this method, we are able to determine the diffusion constant and nuclear membrane permeability coefficients of polyQ proteins as well as the exchange rates between aggregates and the cytoplasm. Our method is based on a reaction-diffusion multi-compartment model defined on a mesh obtained by segmentation of the cell images from the FLIP sequence. The discontinuous Galerkin (DG) method is used for numerical implementation of our model in FEniCS, which greatly reduces the computing time. The method is applied to representative experimental FLIP sequences, and consistent estimates of all transport parameters are obtained. Conclusions: By directly estimating the transport parameters from live-cell image sequences using our new computational FLIP approach surprisingly fast exchange dynamics of mutant Huntingtin between cytoplasm and dim IBs could be revealed. This is likely relevant also for other polyQ diseases. Thus, our method allows for quantifying protein dynamics at different stages of the protein aggregation process in cellular models of neurodegeneration.


2017 ◽  
Author(s):  
Chengfeng Xiao ◽  
Shuang Qiu ◽  
R Meldrum Robertson ◽  
Laurent Seroude

ABSTRACTDrosophila egg-derived tyrosine phosphatase (EDTP, also called JUMPY) is a lipid phosphatase essential in oogenesis and muscle function in the adult stage. Although mammalian JUMPY negatively regulates autophagy, loss-of-JUMPY causes muscle dysfunction and is associated with a rare genetic disorder called centronuclear myopathy. Here we show that tissue-specific downregulation of EDTP in Drosophila non-muscle tissues, particularly glial cells, suppresses the expression of polyglutamine (polyQ) protein aggregates in the same cells and improves survival. Additionally, tissue-specific downregulation of EDTP in glial cells or motoneurons extends lifespan. We demonstrate an approach to fine-tune the expression of a disease-associated gene EDTP for the removal of polyQ protein aggregate and lifespan extension in Drosophila.


2012 ◽  
Vol 287 (35) ◽  
pp. 29722-29728 ◽  
Author(s):  
R. Sean Trevino ◽  
Jane E. Lauckner ◽  
Yannick Sourigues ◽  
Margaret M. Pearce ◽  
Luc Bousset ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-14 ◽  
Author(s):  
Marcel Stark ◽  
Christian Behl

The standardizedGinkgo bilobaextract EGb 761 has well-described antioxidative activities and effects on different cytoprotective signaling pathways. Consequently, a potential use of EGb 761 in neurodegenerative diseases has been proposed. A common characteristic feature of a variety of such disorders is the pathologic formation of protein aggregates, suggesting a crucial role for protein homeostasis. In this study, we show that EGb 761 increased the catalytic activity of the proteasome and enhanced protein degradation in cultured cells. We further investigated this effect in a cellular model of Huntington’s disease (HD) by employing cells expressing pathologic variants of a polyglutamine protein (polyQ protein). We show that EGb 761 affected these cells by (i) increasing proteasome activity and (ii) inducing a more efficient degradation of aggregation-prone proteins. These results demonstrate a novel activity of EGb 761 on protein aggregates by enhancing proteasomal protein degradation, suggesting a therapeutic use in neurodegenerative disorders with a disturbed protein homeostasis.


2002 ◽  
Vol 4 (10) ◽  
pp. 826-831 ◽  
Author(s):  
Soojin Kim ◽  
Ellen A. A. Nollen ◽  
Kazunori Kitagawa ◽  
Vytautas P. Bindokas ◽  
Richard I. Morimoto

2009 ◽  
Vol 284 (17) ◽  
pp. 11318-11325 ◽  
Author(s):  
Jee-Yeon Noh ◽  
Huikyong Lee ◽  
Sungmin Song ◽  
Nam Soon Kim ◽  
Wooseok Im ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document